CFO of troubled NT Pharma heads to Kingsoft
Jul 2, 2012
China vaccine maker refutes fraud allegations after CFO quits
A mysterious letter alleging fraudulent activity at China NT Pharma knocked the vaccine company's stock price off its perch. A sharp refutation from the firm's management has, however, calmed investors for now.
A Hong Kong-listed mainland vaccine maker and drug distributor, China NT Pharma Group Company, saw its stocks rebound after it refuted accusations of false profits that came to light following the departure of its CFO.
Sign in to read on!
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to CorporateTreasurer.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
If you are a treasurer, CFO or senior financial professional at a corporate or SME, please register for free VIP access here.
Questions?
See here for more information on licences and prices, or contact [email protected].
© Haymarket Media Limited. All rights reserved.
Top news, insights and analysis every Tuesday & Thursday
Free registration gives you access to our email newsletters
for unlimited access to all articles, newsletters
